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Abstract: A new technique is being introduced to improve non-palpable breast cancer surgeries.
The purpose of this method is to localize the tumour and the sentinel node using two radioactive
tracers (RT): 125I(Seed) and 99mTc. The present research aims to characterize the detections of
these two RTs using intraoperative gamma probe to determine if the detections are independent. We
validated our proposal by performing experimental tests using the RT separately and simultaneously
in order to visually compare them. The results demonstrated that the interference between 125I and
99mTc detections is nearly irrelevant during the surgery procedure.
I. INTRODUCTION
Breast cancer is the most common cancer in women
worldwide and the second one occurred in both men and
women. In 2018, more than two million of new cases
appeared causing over 600.000 deaths in over the world,
for both sex and all ages [1]. One of the most important
factors in order to reduce its mortality, is practising an
extremely accurate surgery. This issue is especially chal-
lenging when treating patients with non-palpable breast
lesions, since the tumour is impossible to localize exter-
nally. Due to the need to improve localization, much
less invasive and harmful techniques have been developed
during the last decades:
1) Wire localization was the first one introduced. To lo-
calize the tumour a wire is inserted in the center. The
most important disadvantage of this technique is the dis-
location of the wire and therefore, the excision of healthy
tissue.
2) Radioguided Occult Lesion Localization technique
(ROLL) was implemented to overcome the limitations
of the wire localization. In this case, the localization
is reached using Technetium-99m (99mTc). This radioac-
tive tracer (RT) is injected inside the breast lesion and al-
lows its localization using intraoperative gamma probes.
Gamma probes are used to detect the ionizing radiation
from RT and guide the surgeons toward the area of inter-
est. Furthermore, visualizing the lymphatic drainage of
the RT helps the surgeons to identify the Sentinel Node
(SN). SN is the lymph node that directly receives the
drainage of the tumour cells. So that, the examination
of SN evinces whether there is metastasis in breast cancer
patients. The main disadvantage of ROLL is the diffu-
sion of 99mTc resulting in an incorrect margin resection
[2].
3) ROLL using Iodine-125 seed (125I), ROLLIS (Ra-
dioguided Occult Lesion Localization with radioactive
125I Seed) technique, consists in an encapsulated source
(length:4mm, diameter:0,8mm) which avoids tissue mi-
gration and has a limited area of activity. The seed is
implanted preoperatively inside the tumour and is de-
tected using gamma probes. It allows surgeons to per-
form a more precise resection with less volume of healthy
tissue removed.
Nowadays in Spain, surgeries of non-palpable breast can-
cer are being performed using simultaneous use of two
different RTs: 99mTc to locate the SN and 125I(Seed)
guiding to the tumour.
The use of gamma probes under this situation has been
demonstrated to be highly effective[3], but the head doc-
tor of Nuclear Medicine Department of Hospital Clinic
suggest that the technique has not been tested neither
published in Spain. Due to the lack of validation of the
method, the main objective of this work is to character-
ize the intraoperative gamma probes under the detection
of the tumour and SN when using 99mTc and 125I(Seed).
On one hand, the research aims to characterize the main
features of the intraoperative gamma probes detecting
these two RTs, in order to provide the technical proper-
ties of the probes. On the other hand, the purpose is to
verify if the detections of the two RTs are independent or
might have a mutual contribution, to ensure that the tu-
mour excision is based only on the 125I(Seed) activity. So
that, it must be considered during the surgical procedure
by the nuclear medicine physician.
II. METHODS AND MATERIAL
A. Clinical observation
The first step of the experimental part was to perform
complete follow-up of a breast cancer patient at Hospital
Clinic of Barcelona:
1)The nuclear medicine physician implanted the seed
inside the tumour using medical ultrasound, 24 hours
before the surgical procedure. After, the 99mTc was
injected into the tumour in order to drain through
the lymphatic system. Finally, to ensure the correct
localization of the 125I(Seed), a mammography (imaging
technique which uses low-energy X rays to examine
the human breast for diagnosis and screening) was
performed.
2)Three hours later, an SPECT (Single Photon Emission
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Computed Tomography) image was obtained to visualize
both the correct position of the seed and the activity
of 99mTc and 125I. Moreover, a lymphography (nuclear
imaging to visualize the drainage of RT through lym-
phatic system) was performed to visualize the drainage
of 99mTc through the nodes, in order to identify the
SN. Finally, the RTs were detected using the portable
gamma camera to check the localization of 99mTc and
125I using the same equipment than in the operating
room.
3)The surgical procedure was performed the next day:
firstly, the nuclear medicine physician searched the
tumour detecting the radiation emitted from 125I using
the intraoperative gamma probe. Once the tumour was
found, the gynaecological surgeon removed the lesion
and proceeded to analyse it. The same procedure was
performed to localize the SN detecting 99mTc. Once
the surgical procedure was finished, the carcinogenic
tumours were removed. The analysis of SN allows to
know whether there is metastasis so the patient can
start the corresponding therapy.
B. Experimental set-up
The characterized intraoperative gamma probes, con-
sist in an unit control connected to the hand-held. The
probe detects the emitted radiation from RT, shows the
count rate and produces a proportional sound. We de-
cided to use the Navigator GPS TM Standard Lymphatic
Mapping model, which allows us to choose in which en-
ergy window perform the detections, both 125I-channel
and 99mTc-channel [4]. Two kind of probes were charac-
terized: one connected by cable which is shown in Fig(1)
and a wireless probe.
FIG. 1: Required equipment to perform the experimental
tests; the designed stencil and the intraoperative gamma
probe.
To characterize the intraoperative gamma probes for
the detection of the two RT simultaneously, first we
characterised each RT separately. According to clinical
routine, different activities for both RTs were used and
are described in Table(I).
Radionuclide Activity (kBq)
Seed 1 125I 6142
Seed 2 125I 3219





TABLE I: Features of radionuclides used for the gamma
probes characterization.
Having understood the whole process and decided the
required material, some experimental tests were designed
following the Quality Controls of the instrumentation of
Nuclear Medicine [5]. Considering that the possible inter-
ference between the RTs might be from the 99mTc while
detecting 125I from the tumour, the tests were focused
to quantify the interference from 99mTc to 125I detec-
tion. The peak energy of 99mTc is in 140 keV, meanwhile
the 125I one is in 30 keV. Therefore, the scattered radi-
ation due to Compton effect from 99mTc might interfere
with the detection of 125I. In order to perform the exper-
imental tests, a stencil was designed considering all the
measurements described in the quality controls which is
shown in Fig(1) [6].
Finally, the experimental set-up consisted in the intraop-
erative gamma probe which was attached in a fixed po-
sition during all the tests, as it shows Fig(1). The probe
shows in the screen the number of counts detected pro-
portionally to the radiation detected. During the tests,
RTs where placed in the designed stencil and were moved
spatially and angularly: 125I as an encapsulated source
and 99mTc as liquid sample placed in a small plastic bub-
ble. The experimental procedure consisted in collecting
the number of counts from different RTs’ position.The
experiments were conducted to characterize the gamma
probes analysing its properties:
• Sensitivity: is the count rate per unit of the activ-
ity produced by the radionuclide and quantifies the
smallest variation that can be appreciated by the
probe. To characterize the sensitivity, we measured
the number of counts detected by the probe moving
the radionuclide every 1 cm from 0 to 15 cm, being
aligned with the probe.
• Angular and spatial resolution: quantifies the min-
imum angular and spatial distance between two
distant objects that the probe can discern. We
measured the maximum number of counts that oc-
curred when the probe and the radionuclide were
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aligned. Then the half of maximum counts was
used to calculate the Full Width at Half Maximum
(FWHM). The procedure was performed at 3cm
and 30cm as it is defined in [5].
• Directionality: because 125I is an encapsulated
source, it was necessary to analyse the variation
of the count rate, according to the relative angle
between the probe and the 125I(Seed). The direc-
tionality of 99mTc has no sense since it is liquid.
We measured the number of counts by rotating the
seed every 15◦. The procedure was performed from
0◦ to 180◦.
III. RESULTS
The experimental tests were performed using both
probes, the wireless one and the wired. Unfortunately,
using the wireless probe, a malfunction of the probe was
evidenced. The Nuclear Medicine Department was noti-
fied and the probe was removed from the surgical practise
and sent it for repair.
Accordingly, the experimental tests were performed using
only the wired-probe.
A. Using 99mTc and 125I separately
• Sensitivity:
The results from the measures from the three seeds
detected in the 125I- channel can be seen in Fig(2).
The same results for three different activities of
99mTc using both 125I-channel and 99mTc-channel
are shown in Fig(4) and Fig(3), respectively. In
all cases we observe the dependence between sen-
sitivity and distance, from RT to the probe, as
Sensitivity ∝ 1
D2 . The main observable difference be-
tween measurements is the sensitivity scale: in one
hand, when detecting 99mTc using 99mTc-channel
the sensitivity of the probe is maximum since the
99mTc peak is 140keV compared to the 30keV of
the 125I peak. The difference between the maxi-
mum sensitivities detecting 99mTc or 125I, is about
20 no.counts/kBq. On the other hand, when de-
tecting 99mTc in the 125I-channel, sensitivity is the
lowest. In this case just the scattered from 99mTc
in 125I window was detected, so the maximum sen-
sitivity decreases until a factor of 10. Furthermore,
we can appreciate, in the area of small distances,
the effects of dead time on senstivity.
• Spatial and angular resolution:
Experimental tests were performed using the dif-
ferent seeds measured in the 125I-channel, and two
different activities of 99mTc measured both in the
125I-channel and 99mTc-channel. FWHM was cal-
culated and defines the spatial and the angular res-
olution. Analysing the results, shown in Table(II),
we can verify that the resolution is independent
FIG. 2: Relation between the sensitivity and distance when
the seeds and the probe are aligned. Measurements have been
performed in the 125I-channel.
FIG. 3: Relation between sensitivity and distance when the
different activities of 99mTc and the probe are aligned. Mea-
surements have been performed in the 99mTc-channel.
FIG. 4: Relation between the sensitivity and distance when
different activities of 99mTc and the probe are aligned. Mea-
surements have been performed in the 125I-channel.
from different activities, so resolution is an intrin-
sic feature of the probe. The slight variations could
be as consequence of experimental errors.
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RT-Channel SR at D=3cm SR at D=30cm AR at D=3cm AR at D=3cm
Seed1-I 1 2,53 18,19 52,49 42,06
Seed2-I 2,65 20,42 52,14 41,41
Seed3-I 2,74 19,49 52,58 42,32
Tc10-Tc 3,10 18,31 60,97 51,39
Tc10-I 2,83 23,72 60,17 56,07
Tc25-Tc 3,13 24,58 63,42 50,86
Tc25-I 3,06 26,11 62,54 48,90
TABLE II: Spatial (SR) and angular (AR) resolution, in cm
and ◦ respectively, for the tested seeds using 125I-channel and
for different activities of 99mTc using both 125I-channel and
99mTc channel, at 3cm and 30cm. Referee to Table(I) for the
names of RTs.
• Directionality:
Directionality test (Fig(5)) presents unexpected re-
sults: the number of counts has a peak when the
probe and the 125I(Seed) are arranged with a rela-
tive angle of 90◦. The only difference between the
results from the different seeds is the number of
detected counts which increases with higher activ-
ities.
FIG. 5: Relation between the detected number of counts and
the relative angle between the probe and the 125I(Seed).
B. Using 99mTc and 125I simultaneously
We used the lower activity seed (Seed3) and 99mTc
with the higher activity (Tc25) to characterize the intra-
operative gamma probes on the simultaneous detection
of 125I and 99mTc. This is the worst scenario to localize
the 125I(Seed) because of the larger contribution of 99mTc
in the detection of the lowest 125I activity. Therefore, we
assumed that by studying this situation, we could apply
the conclusions to the other RTs’ combinations.
• Sensitivity:
The test was performed locating Seed3 and Tc20
in the same position at different distances from
the probe. The results evidenced that the depen-
dence between sensitivity and distance is the same
in both cases, using only 125I and adding 99mTc, as
it can be seen in Fig(6). Sensitivity decreases with
distance, as it was demonstrated using RTs sepa-
rately. When adding 99mTc in the same localization
than the seed, the variation due to the detection of
the scatter radiation emitted from 99mTc, is almost
negligible at visual inspection.
FIG. 6: Relation between the sensitivity and distance when
the RTs and the probe are aligned. Measurements have been
performed in the 125I-channel.
• Spatial and angular resolution:
Due to the complexity on performing the resolu-
tion experimental test using the two RTs simulta-
neously, this test was not executed experimentally
and a numerical simulation was performed to study
the expected effects. Knowing that the RTs detec-
tion follows a Gaussian distributions, both peaks
were simulated using the results obtained from the
resolution experimental test using 125I and 99mTc
separately (Table(II)). 99mTc peak was simulated
as it was at a certain distance from the 125I peak,
representing the real situation where the tumour is
fixed in a location and the SN’s location depends
on the lymphatic drainage.
The result of the simulation is shown in Fig(7)
where the tumour and the SN are separated 5cm.
The centered peak corresponds to Seed3 detection
and the lower one to the detection of the scattered
radiation from Tc25 in the 125I window. In this





Where d12 is the distance between the minimum
1 and the maximum 2 and h2 is the height of the
maximum 2.
The real distance between SN and tumour is be-
tween 5 and 15cm, therefore distinguishing the two
simulated peaks following the criteria shown in
Fig(7), we can conclude that the location of tumour
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FIG. 7: Simulation of the number of counts detected based
on distance from the seed (in cm), using 125I and 99mTc si-
multaneously separated 5cm each other.
is independent of the radiation emitted from the
location of SN. It has to be considered that, if the
simulation is performed using a separation of 4cm
it becomes impossible to distinguish the peaks and
contribution between the detection appears. Any-
way, is out of the interval with medical interest.
IV. DISCUSSION
Clinical observation allowed us to become aware within
the medical context on the present project is based. Ex-
perimental tests using the RTs separately, allowed us to
characterize the gamma probe in both detections and
both channels. Having quantified the different features
as sensitivity or resolution, all the technical information
was provided to the nuclear medicine physician. The re-
sults obtained from directionality were unknown by the
medical experts, being of significant importance to con-
sider the maximum detection of seed’s radiation when
the relative angle is 90◦ approximately. Therefore, the
physician should be aware that, during the surgical pro-
cedure, any deviation from this angle will decrease the
counting rate, which not implies that the probe could be
moving away from the seed.
From the results obtained from experimental test using
the RTs simultaneously, we demonstrated that the exci-
sion of the tumour guided by the detection of 125I(Seed)
is successful and the contribution of 99mTc scatter is al-
most irrelevant during the surgical procedure. On one
hand, we have seen that the variation on sensitivity when
detecting in the 125I-channel only 125I(Seed) or adding
99mTc is almost negligible. Therefore, in terms of sen-
sitivity, there is no contribution from the scatter from
99mTc. On the other hand, as regards resolution, we ob-
served that during the detection of 125I for locate the tu-
mour, 99mTc radiation emitted from SN at the simulated
distance is almost not contributing. As a conclusion, the
tumour excision is based mainly on the 125I(Seed) activ-
ity.
V. CONCLUSIONS
This research aimed to characterize the intraoperative
gamma probes that are used in surgical procedure quanti-
fying the sensitivity, spatial and angular resolution. Also,
it was demonstrated that the directionality of the seed is
a fact that it must be taken into account during the sur-
gical procedures. Finally, the possible mutual contribu-
tions between 125I and 99mTc have been demonstrated to
be almost negligible during the non-palpable breast can-
cer surgeries. On balance, the purpose of the project is
totally achieved. Once set out all the results, next step
will be their validation in a clinical context during the
surgical procedure.
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